Acacia Patent Acquisition

Acacia Research is a publicly traded investment firm (Nasdaq: ACTG) that specializes in acquiring and managing businesses and intellectual property assets, with a significant focus on the life sciences, technology, and industrial sectors. Operating through subsidiaries like Acacia Research Group (formerly Acacia Patent Acquisition), the company specializes in the acquisition, development, and licensing of patent portfolios, including those related to medical devices, diagnostics, and biotechnology. In 2020, Acacia significantly expanded its healthcare footprint by acquiring a £223.9 million portfolio of life science assets from the Woodford Equity Income Fund, which included equity stakes in prominent companies such as Oxford Nanopore Technologies and Immunocore. The company acts as a value-oriented acquirer, leveraging its capital resources and governance expertise to monetize intellectual property and drive growth in its operating subsidiaries. Acacia's life science interests span a wide range of therapeutic areas and diagnostic technologies, positioning it as a key player in the monetization of healthcare innovation. The firm is well-known for its strategic partnership with Starboard Value LP, which provides financial and operational support for its acquisition strategy.